Immunomodulation, IL-1 Inhibition, and Postoperative Incisional Pain
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
California
-
Stanford, California, 미국, 94305
- Stanford Hospital and Clinics
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-Patients 18 years of age and older presenting to the Stanford Preoperative Evaluation Clinic prior to elective orthopedic surgical procedures or elective vascular surgical procedures not involving the abdominal aorta or carotid arteries.
Exclusion Criteria:
Patients will be excluded from participation if they have one or more of the following conditions:
- Evidence of active local or systemic infection as demonstrated by fever, leukocytosis (white blood cell count > 11,000/ul), productive cough, new infiltrate on chest x-ray, or purulent drainage from any source
- End-stage renal disease
- A history of diabetic neuropathy
- A malignancy other than basal cell carcinoma of the skin or in situ carcinoma of the cervix within the previous 5 years
- Leukopenia (white blood cell count < 2,000/ul)
- Thrombocytopenia (platelet count < 100,000/ul)
- Abnormal liver function test result (aspartate aminotransferase or alanine aminotransferase level ≥1.5-fold the upper limit of normal)
- A history or infection with tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus
- Pregnant or breastfeeding
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
활성 비교기: Anakinra
Two subcutaneous injections of anakinra (IL-1ra) were given, the first one hour prior to surgery and the second 24 hours after surgery.
|
An injection of 100 mg Anakinra was administered 1 hour prior to surgery and again 24 hours following surgery.
다른 이름들:
|
|
위약 비교기: Saline injection
Two subcutaneous injections of normal saline (same volume as the anakinra group injection) were given, the first one hour prior to surgery and the second 24 hours after surgery.
|
An injection of normal saline was administered 1 hour prior to surgery and again 24 hours following surgery.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Concentration Levels of Inflammatory Mediators IL-1 Receptor Antagonist (IL-1ra) Present in Human Wounds Following Surgery With and Without the Use of Anakinra.
기간: Up to 72 hours following surgery
|
Tissue samples were collected at the surgical wound site at 3 time points during the 1st 72 hours following surgery.
Tissue samples from subjects receiving placebo, and subjects receiving anakinra injections pre, and post op were analyzed for IL-1
|
Up to 72 hours following surgery
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Number of Participants With Analgesic Consumption During the 72 Hours Following Surgery
기간: Up to 72 hours following surgery
|
Analgesic consumption is reported as the count of participants receiving each analgesic type. Comparisons between the placebo and active drug groups were made at the conclusion of the study. PCA/IV: Patient controlled Analgesia/ Intravenous |
Up to 72 hours following surgery
|
|
Post-operative Pain Intensity
기간: Up to 72 hours following surgery
|
Pain was measured on Day 1 and day 2 following surgery using a VAS scale at rest and on stimulation with Visual Analog Scale (VAS) of 1-10 (1=no pain and 10=worst pain)
|
Up to 72 hours following surgery
|
|
Count of Participants Experiencing Wound Infection in the Study From Surgery Till the Time of Discharge From the Hospital
기간: Up to 72 hours following surgery plus 3 weeks follow-up
|
Evaluation of the surgical wound for symptoms of wound infection was made every day during hospitalization.
Records from the first post-operative clinic visit were also evaluated for evidence of wound infection.
|
Up to 72 hours following surgery plus 3 weeks follow-up
|
|
Count of Participants With Venous Thrombosis After Surgery During Hospitalization
기간: Up to 72 hours following surgery plus 3 weeks follow-up
|
Evaluation of the surgical wound for symptoms of venous thrombosis was made every day during hospitalization.
Records from the first post-operative clinic visit were also evaluated for evidence of venous thrombosis.
|
Up to 72 hours following surgery plus 3 weeks follow-up
|
|
Assess Rates of Wound Dehiscence
기간: Up to 72 hours following surgery plus 3 weeks follow-up
|
Evaluation of the surgical wound for symptoms of wound dehiscence was made every day during hospitalization.
Records from the first post-operative clinic visit were also evaluated for evidence of wound dehiscence.
|
Up to 72 hours following surgery plus 3 weeks follow-up
|
|
Total Length of Hospital Stay
기간: Up to approximately 5 days maximum (admittance to discharge)
|
Total length of hospital stay for patients enrolled in the study.
|
Up to approximately 5 days maximum (admittance to discharge)
|
공동 작업자 및 조사자
수사관
수사관
- 수석 연구원: Robert L Lobato, MD, Stanford U
연구 기록 날짜
연구 주요 날짜
연구 시작
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (실제)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- SU-10312011-8587
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .